Literature DB >> 1652568

Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma.

P Laurent-Puig1, S Olschwang, O Delattre, P Validire, T Melot, V Mosseri, R J Salmon, G Thomas.   

Abstract

The occurrence of a point mutation on the 12th and 13th codons of the Ki-ras oncogene has been investigated in 99 colorectal carcinomas in relation to 3 histological parameters: extent of differentiation, occurrence of a mucinous component within the tumor, and presence of peripheral adenomatous polyp remnants. The mutation frequency increased with each parameter: from 13% (2/15) to 44% (37/84) with differentiation, from 33% (26/79) to 65% (13/20) with mucinous character, and from 27% (15/56) to 56% (24/43) with the presence of polyp remnants. The frequency was highest in well-differentiated mucinous tumors with adenomatous remnants 83% (5/6). We suggest that Ki-ras mutation is preferentially involved in carcinomas that have developed from adenoma and that the mutation preserves differentiation and mucin secretion in these cancer cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652568     DOI: 10.1002/ijc.2910490213

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.

Authors:  Charly Liddell; Laure Droy-Dupré; Sylvie Métairie; Fabrice Airaud; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Mod Pathol       Date:  2017-04-21       Impact factor: 7.842

2.  Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.

Authors:  H Paraskevakou; A Saetta; K Skandalis; S Tseleni; A Athanassiadis; P S Davaris
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  Expression of p53 and p21 protein in transitional mucosa adjacent to rectal carcinoma and its clinical implication.

Authors:  M Feng; F Pei; G Yang; Z Mao; S Wang
Journal:  J Tongji Med Univ       Date:  2000

4.  Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.

Authors:  Jy-Ming Chiang; Yah-Huei Wu Chou; Shih-Chieh Ma; Jim-Ray Chen
Journal:  Virchows Arch       Date:  2004-09-24       Impact factor: 4.064

5.  Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

Authors:  Zuo Yunxia; Cao Jun; Zhu Guanshan; Lu Yachao; Zhou Xueke; Li Jin
Journal:  BMC Med Genet       Date:  2010-02-26       Impact factor: 2.103

6.  Particularly interesting new cysteine-histidine rich protein expression in colorectal adenocarcinomas.

Authors:  Zeng-Ren Zhao; Zhi-Yong Zhang; Dong-Sheng Cui; Li Jiang; Hui-Jun Zhang; Ming-Wei Wang; Xiao-Feng Sun
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

7.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

8.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location.

Authors:  J Breivik; G I Meling; A Spurkland; T O Rognum; G Gaudernack
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

10.  Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma.

Authors:  J W Mulder; I O Baas; M M Polak; S N Goodman; G J Offerhaus
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.